Anne Frese
Human Resources Officer presso MEI PHARMA, INC.
Profilo
Anne Frese is currently the Chief People Officer at MEI Pharma, Inc. Her former jobs include being the Vice President of Human Resources at Bellicum Pharmaceuticals, Inc. from 2015 to 2018, and the Vice President of Human Resources at Artiva Biotherapeutics, Inc. from 2019 to 2021.
She also held the position of Chief Human Resources Officer at Vyripharm Enterprises LLC.
Ms. Frese received her undergraduate degree from McGill University.
Posizioni attive di Anne Frese
Società | Posizione | Inizio |
---|---|---|
MEI PHARMA, INC. | Human Resources Officer | 22/06/2022 |
Precedenti posizioni note di Anne Frese
Società | Posizione | Fine |
---|---|---|
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Human Resources Officer | 01/07/2021 |
BELLICUM PHARMACEUTICALS, INC. | Human Resources Officer | 01/07/2018 |
Vyripharm Enterprises LLC
Vyripharm Enterprises LLC BiotechnologyHealth Technology Vyripharm Enterprises LLC operates biotechnology company which develops drugs for cancer and metabolic diseases. The company is headquartered in Houston, TX. | Human Resources Officer | - |
Formazione di Anne Frese
McGill University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
MEI PHARMA, INC. | Health Technology |
Aziende private | 3 |
---|---|
Bellicum Pharmaceuticals, Inc.
Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
Vyripharm Enterprises LLC
Vyripharm Enterprises LLC BiotechnologyHealth Technology Vyripharm Enterprises LLC operates biotechnology company which develops drugs for cancer and metabolic diseases. The company is headquartered in Houston, TX. | Health Technology |
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Anne Frese